Morgan Stanley raised the firm’s price target on Vertiv (VRT) to $165 from $125 and keeps an Overweight rating on the shares following the Q2 report. The firm views the company’s first half of the year results as “phenomenal” with its organic accelerating to 30% and the company adding another $1.3B of backlog. However, Morgan Stanley is getting more cautious on the stock’s valuation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRT:
- Vertiv Holdings: Strong Growth Prospects and Investment Opportunity Despite Temporary Margin Challenges
- Cisco, Texas Instruments, Vertiv, Coinbase, Paramount: Trending by Analysts
- Vertiv price target raised to $162 from $133 at TD Cowen
- Vertiv price target raised to $173 from $135 at UBS
- Vertiv price target raised to $151 from $140 at Oppenheimer
